Mark A Labow

Title: Mark A Labow: Innovator in Immunology

Introduction

Mark A Labow is a notable inventor based in Westfield, NJ (US). He has made significant contributions to the field of immunology, particularly through his innovative patents. With a total of 2 patents, Labow's work focuses on critical aspects of inflammatory and immune responses.

Latest Patents

Labow's latest patents include groundbreaking inventions that address important medical challenges. One of his patents is related to an interleukin-1 related gene and protein. This invention discloses a protein that is highly homologous to known interleukin-1 cytokines, along with nucleic acid molecules that encode such a protein, antibodies that recognize the protein, and methods for diagnosing conditions related to host inflammatory and immune responses. Another significant patent is for a mammary gland chemokine. This invention provides various methods for utilizing a polypeptide encoding a chemokine (MEC) and a polypeptide translated therefrom. The MEC chemokine is underexpressed in tumors, making it a useful marker for diagnosis and prognosis of adverse bodily reactions.

Career Highlights

Throughout his career, Labow has worked with prominent companies, including Novartis Corporation. His contributions have been instrumental in advancing research and development in the pharmaceutical industry.

Collaborations

Labow has collaborated with notable professionals in his field, including Vadim Iourgenko and Craig Stephen Mickanin. These collaborations have further enriched his research and innovation efforts.

Conclusion

Mark A Labow's contributions to immunology through his patents and collaborations highlight his role as a significant innovator in the field. His work continues to impact the understanding and treatment of inflammatory and immune-related conditions.